Monthly News Roundup – September 2020
Genentech’s Gavreto Cleared for RET Fusion-Positive NSCLC Gavreto (pralsetinib) is a RET kinase inhibitor used for the treatment of adults
Read more
Genentech’s Gavreto Cleared for RET Fusion-Positive NSCLC Gavreto (pralsetinib) is a RET kinase inhibitor used for the treatment of adults
Read moreRoundup IS cancerous, jury declares Groundsman, 46, is awarded $289M by jury in historic trial that ruled weedkiller Roundup DID
Read more